Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
5,578,947
-
Total 13F shares
-
473,865
-
Share change
-
-9,935
-
Total reported value
-
$2,464,434
-
Price per share
-
$5.20
-
Number of holders
-
17
-
Value change
-
-$16,115
-
Number of buys
-
6
-
Number of sells
-
7
Institutional Holders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) as of Q1 2024
As of 31 Mar 2024,
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
473,865 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Tower Research Capital LLC (TRC), MORGAN STANLEY, and CALDWELL SUTTER CAPITAL, INC..
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.